First Time Loading...

ImpediMed Ltd
ASX:IPD

Watchlist Manager
ImpediMed Ltd Logo
ImpediMed Ltd
ASX:IPD
Watchlist
Price: 0.086 AUD -4.44% Market Closed
Updated: Apr 28, 2024

Wall Street
Price Targets

IPD Price Targets Summary
ImpediMed Ltd

Wall Street analysts forecast IPD stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for IPD is 0.184 AUD with a low forecast of 0.141 AUD and a high forecast of 0.21 AUD.

Lowest
Price Target
0.141 AUD
64% Upside
Average
Price Target
0.184 AUD
113% Upside
Highest
Price Target
0.21 AUD
144% Upside
ImpediMed Ltd Competitors:
Price Targets
6869
Sysmex Corp
29% Upside
048260
OsstemImplant Co Ltd
0% Downside
206640
Boditech Med Inc
38% Upside
MYO
Myomo Inc
64% Upside
BIM
Biomerieux SA
12% Upside
3600
Modern Dental Group Ltd
4% Upside
78W
Modulight Oyj
136% Upside
9996
Peijia Medical Ltd
250% Upside

Revenue
Forecast

Revenue Estimate
ImpediMed Ltd

For the last 8 years the compound annual growth rate for ImpediMed Ltd's revenue is 11%. The projected CAGR for the next 3 years is 47%.

11%
Past Growth
47%
Estimated Growth
Estimates Accuracy
-15%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ImpediMed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

Net Income
Forecast

Net Income Estimate
ImpediMed Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-77%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is IPD's stock price target?
Price Target
0.184 AUD

According to Wall Street analysts, the average 1-year price target for IPD is 0.184 AUD with a low forecast of 0.141 AUD and a high forecast of 0.21 AUD.

What is ImpediMed Ltd's Revenue forecast?
Projected CAGR
47%

For the last 8 years the compound annual growth rate for ImpediMed Ltd's revenue is 11%. The projected CAGR for the next 3 years is 47%.